A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...

Dr Veeru Kasivisvanathan (UCL Division of Surgery & Interventional Science) has been awarded the prestigious Society of ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Everyone’s body is different, and what may work for one patient in surgery may not work for another. Doctors at Tampa General ...

Down almost 70% from all-time highs, Profound Medical is an undervalued growth stock that offers significant upside potential ...

Market OverviewThe global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period.

A world-first study shows stabilised hyaluronic acid gel can safely protect the rectum during radiation therapy for ...

Heriot-Watt spin-out Less Grey Imaging is shortlisted for a major health technology award for its AI-driven prostate cancer imaging innovation.

Full-body MRI scans are gaining popularity, but doctors warn their benefits may not outweigh the risks for healthy, symptom-free individuals. While MRIs can detect certain cancers and abnormalities, ...

On 16 January 2026, Telix Pharmaceuticals announced that the first U.S. patient had been dosed in BiPASS, a Phase 3 trial evaluating Illuccix and Gozellix PSMA-PET imaging alongside MRI for initial ...

In the first-ever study, Australian researchers have demonstrated the feasibility and safety of using stabilised hyaluronic acid (sHA) gel during radiation treatment for gynaecological cancers.